India In Vitro Diagnostics Market: Driving Forces and Disruptive Trends [2030]

Written by Kumar Satyam  »  Updated on: November 19th, 2024

According to TechSci Research report, “India In Vitro Diagnostics Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2020-2030F”, India In Vitro Diagnostics Market was valued at USD 1.74 billion in 2024 and is anticipated to witness impressive growth in the forecast period with a CAGR of 5.45% through 2030. This growth can be attributed to collaborations and partnerships among leading companies aiming to merge their expertise and strengthen their market positions.

Emerging Trends: What’s Driving the Change?

The Indian in-vitro diagnostics (IVD) market is experiencing rapid transformation driven by several emerging trends. Innovations such as remote collection and digital pathology are revolutionizing the way diagnostic services are delivered. For instance, in October 2022, Proscia launched an expanded digital platform, Concentriq Dx, to streamline primary diagnostic workflows. Similarly, Roche’s next-generation VENTANA DP 600 slide scanner, launched in June 2022, enhances the quality of histology slide imaging, providing flexibility and ease of use for pathology labs.

Technological advancements in healthcare, including biosensors, lab-on-a-chip, and wearable devices, are becoming integral parts of the healthcare landscape. Point-of-care (POC) diagnostics, which bring testing closer to patients and expedite diagnosis and treatment, are increasingly adopted across India.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on India In Vitro Diagnostics Market

How Does Regulatory Scenario Shape this Industry?

Regulations play a crucial role in shaping the IVD market in India. Stringent regulatory frameworks ensure the safety, efficacy, and quality of diagnostic products. However, these regulations can also pose challenges, such as lengthy approval processes and complex compliance requirements. The Indian government has been proactive in updating its regulatory guidelines to keep pace with technological advancements. Initiatives like the Medical Device Rules, 2017, aim to streamline the approval process for new diagnostic devices while maintaining high standards of safety and performance.

Drivers: What Fuels the Market Growth?

Rising Prevalence of Chronic Diseases

One of the primary drivers of the Indian IVD market is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. According to the ICMR 2021 Report, the number of cancer patients in India is projected to rise from 26.7 million in 2021 to 29.8 million by 2025. Similarly, statistics from the International Diabetes Federation (IDF) indicate that the number of people with diabetes in India is expected to increase from 74.1 million in 2022 to 92.9 million by 2030.

Increased Healthcare Awareness

Greater healthcare awareness is another significant factor driving the demand for IVD. Awareness campaigns and health screening programs are encouraging individuals to adopt preventive healthcare measures, including regular check-ups and diagnostic testing. These initiatives help in early disease detection and management, thereby increasing the demand for diagnostic tests.

Technological Innovations

Technological advancements are propelling the IVD market forward. Innovations such as remote sample collection, digital pathology, and advanced imaging techniques are improving diagnostic accuracy and efficiency. The launch of products like Proscia’s Concentriq Dx platform and Roche’s VENTANA DP 600 slide scanner exemplifies the impact of technology on the market.

Market Segmentation: Who are the Key Players?

Top 10 Companies

  1. Abbott India Limited
  2. Danaher (DHR) Holding India Pvt Limited
  3. Roche Diagnostics India Pvt. Ltd.
  4. bioMérieux India Private Limited
  5. Transasia Bio-Medicals Ltd.
  6. bioMérieux India Limited
  7. Becton Dickinson Private Limited
  8. Thermo Fisher Scientific India Pvt. Ltd.
  9. Siemens Healthcare Private Limited
  10. Sysmex India Pvt. Ltd

Discover Who You Really Compete Against In The Marketplace, Get PDF Sample Report Now! @ https://www.techsciresearch.com/sample-report.aspx?cid=7302

Top Segments

The Indian IVD market is segmented based on product, test type, usability, end-user, application, and region. In 2024, hospitals and clinics held the largest market share and are expected to continue expanding. The high patient volume and the comprehensive range of services offered by these facilities drive the demand for diagnostic tests. Specialized care units within hospitals further boost the demand for IVD products.

Industry Key Highlights

The Indian IVD market has witnessed several significant developments in recent years. Companies are actively engaged in developing new products and forming strategic partnerships. For example, in September 2021, Mylab Discovery Solutions acquired a majority stake in Sanskritech, a developer of portable diagnostic systems. In August 2021, Mylab partnered with Hemex Health to develop next-generation POC diagnostic solutions.

Future Outlook: What Lies Ahead?

The future of the Indian IVD market looks promising, driven by continued technological advancements, increasing healthcare awareness, and a rising burden of chronic diseases. The market is expected to grow at a CAGR of 5.45% through 2030, reaching new heights in terms of value and volume.

10 Benefits of the Research Report

  1. Comprehensive Market Analysis: Provides an in-depth analysis of market trends, drivers, and challenges.
  2. Emerging Trends Insight: Highlights key emerging trends shaping the market.
  3. Regulatory Overview: Detailed analysis of regulatory scenarios and their impact on the market.
  4. Competitive Landscape: Comprehensive competitive analysis of key market players.
  5. Market Segmentation: Detailed segmentation analysis based on product, test type, usability, end-user, application, and region.
  6. Growth Projections: Forecasts market growth with a detailed analysis of growth drivers.
  7. Technological Innovations: Highlights technological advancements and their impact on the market.
  8. Strategic Recommendations: Provides actionable insights and strategic recommendations for market players.
  9. Market Opportunities: Identifies key opportunities for market players to capitalize on.
  10. Investment Analysis: Offers insights into potential investment opportunities in the market.

Competitive Analysis: How are Companies Positioning Themselves?

The competitive landscape of the Indian IVD market is characterized by intense rivalry among key players. Companies are focusing on strategic initiatives such as mergers and acquisitions, partnerships, and new product launches to strengthen their market positions.

For instance, in June 2022, Genes2Me Pvt. Ltd launched the CoviEasy Self-test Rapid Antigen kit for COVID-19, supported by an AI-driven mobile app. Similarly, in February 2022, Mylab Discovery Solutions launched CoviSwift, a POC testing solution for COVID-19 that processes 16 samples within 40 minutes, significantly faster than traditional RT-PCR tests.

Mergers and Acquisitions

Mergers and acquisitions are a common strategy among market players to expand their product portfolios and enhance their market presence. Mylab’s acquisition of Sanskritech is a notable example, enabling the company to establish POC testing systems in various settings, including doctor offices, nursing homes, and airports.

Partnerships and Collaborations

Partnerships and collaborations are another key strategy employed by market players. Mylab’s technology partnership with Hemex Health to develop next-generation diagnostic solutions exemplifies this approach. Such collaborations enable companies to leverage each other’s strengths and expertise, driving innovation and market growth.

Product Launches

Continuous product innovation and launches are critical for staying competitive in the IVD market. The introduction of advanced diagnostic tools, such as Proscia’s Concentriq Dx platform and Roche’s VENTANA DP 600 slide scanner, underscores the importance of technological advancements in driving market growth.

The Indian In Vitro Diagnostics Market is poised for significant growth in the coming years. Driven by rising healthcare awareness, increasing prevalence of chronic diseases, and continuous technological advancements, the market offers numerous opportunities for key players. Despite regulatory challenges, the market’s future looks promising, with robust growth projections and numerous strategic initiatives by leading companies. The comprehensive insights provided in this research report will help stakeholders make informed decisions and capitalize on the emerging opportunities in the Indian IVD market.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“With a burgeoning middle class and expanding healthcare infrastructure, there's a shift towards preventive healthcare, boosting demand for diagnostics. Innovative solutions like point-of-care testing and molecular diagnostics are gaining traction, enabling quicker and more accurate disease detection. Government initiatives to enhance healthcare accessibility and affordability will further propel market expansion. Collaboration between local and international players will foster expertise interchange, driving the development of tailored diagnostic solutions for India's diverse healthcare landscape.," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

"India In Vitro Diagnostics Market By Product (Instrument, Reagent, Other Products), By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, Other Types), By Usability (Disposable In Vitro Diagnostics Devices, Reusable In Vitro Diagnostics Devices), By Application (Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease, Nephrology, Others), By End User (Diagnostic Laboratories, Hospitals & Clinics, Others), By Region, Competition and Opportunities, 2020-2030F" has evaluated the future growth potential of India In Vitro Diagnostics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India In Vitro Diagnostics Market.

Discover Who You Really Compete Against In The Marketplace, Get PDF Sample Report Now! @ https://www.techsciresearch.com/sample-report.aspx?cid=7302

Related Reports-

Japan Virtual Clinical Trials Market

Japan Over The Counter (OTC) Analgesics Market

Japan Blockchain Technology In Healthcare Market

Contact

US -

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Web: https://www.techsciresearch.com/


Disclaimer:

We do not claim ownership of any content, links or images featured on this post unless explicitly stated. If you believe any content or images infringes on your copyright, please contact us immediately for removal ([email protected]). Please note that content published under our account may be sponsored or contributed by guest authors. We assume no responsibility for the accuracy or originality of such content. We hold no responsibilty of content and images published as ours is a publishers platform. Mail us for any query and we will remove that content/image immediately.